Neuberger Berman Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.77M Buy
27,413
+477
+2% +$33.6K ﹤0.01% 1222
2025
Q4
$1.81M Sell
26,936
-838
-3% -$56.4K ﹤0.01% 1213
2025
Q3
$2.04M Sell
27,774
-154,826
-85% -$10.3M ﹤0.01% 1161
2025
Q2
$9.5M Sell
182,600
-279,927
-61% -$15.9M 0.01% 809
2025
Q1
$29.5M Buy
462,527
+86,981
+23% +$5.05M 0.02% 539
2024
Q4
$18M Buy
375,546
+89,464
+31% +$4.59M 0.01% 687
2024
Q3
$16.4M Buy
286,082
+9,059
+3% +$519K 0.01% 700
2024
Q2
$14.5M Buy
277,023
+17,342
+7% +$761K 0.01% 711
2024
Q1
$10.6M Buy
259,681
+83,225
+47% +$3.12M 0.01% 777
2023
Q4
$6.52M Sell
176,456
-7,997
-4% -$301K 0.01% 853
2023
Q3
$7.05M Buy
184,453
+1,542
+0.8% +$63.2K 0.01% 808
2023
Q2
$6.6M Buy
182,911
+41,590
+29% +$1.42M 0.01% 830
2023
Q1
$5.4M Buy
141,321
+6,909
+5% +$324K 0.01% 860
2022
Q4
$7.65M Sell
134,412
-43,849
-25% -$2.24M 0.01% 797
2022
Q3
$7.05M Buy
178,261
+2,907
+2% +$128K 0.01% 809
2022
Q2
$7.72M Buy
175,354
+9,079
+5% +$393K 0.01% 801
2022
Q1
$6.63M Buy
166,275
+6,854
+4% +$244K 0.01% 896
2021
Q4
$6.35M Sell
159,421
-438
-0.3% -$16.4K 0.01% 925
2021
Q3
$6.42M Sell
159,859
-71,203
-31% -$2.98M 0.01% 897
2021
Q2
$10.5M Buy
231,062
+17,907
+8% +$793K 0.01% 814
2021
Q1
$8.89M Buy
213,155
+64,399
+43% +$2.94M 0.01% 841
2020
Q4
$6.35M Buy
148,756
+2,006
+1% +$72.1K 0.01% 860
2020
Q3
$3.86M Buy
146,750
+34,000
+30% +$947K ﹤0.01% 913
2020
Q2
$3.02M Buy
112,750
+33,000
+41% +$744K ﹤0.01% 923
2020
Q1
$1.44M Buy
+79,750
New +$1.51M ﹤0.01% 1017
2018
Q1
Sell
-40,000
Closed -$810K 1705
2017
Q4
$810K Buy
+40,000
New +$735K ﹤0.01% 1277
2013
Q3
Sell
-11,000
Closed -$87K 1629
2013
Q2
$87K Buy
+11,000
New +$70.1K ﹤0.01% 1544

Other funds holding HALO

Neuberger Berman Group's HALO Position: Q1 2026 in Review

Neuberger Berman Group increased its Halozyme (HALO) stake by 1.8% in Q1 2026, buying an estimated $33.6K and bringing the position to 27,413 shares worth $1.77M. The position accounts for ﹤0.01% of the portfolio, ranked #1222.

Neuberger Berman Group first reported a position in HALO in Q2 2013 and has held it in 27 quarters since. The position peaked at $29.5M in Q1 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Neuberger Berman Group held 27,413 shares of Halozyme worth $1.77M as of Q1 2026.
  • Neuberger Berman Group bought 477 Halozyme shares in Q1 2026, an estimated $33.6K.
  • Halozyme made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #1222 holding.
  • Neuberger Berman Group first reported a position in Halozyme in Q2 2013 and has held it in 27 quarters since.
  • Neuberger Berman Group's Halozyme position peaked at $29.5M in Q1 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.